Tenofovir Disoproxil Fumarate CAS 202138-50-9 Assay 98.0%~102.0% API Factory
Ubonelelo ngezoRhwebo lwe-Tenofovir oluNxulumene naMaphakathi:
I-Tenofovir CAS: 147127-20-6
I-Tenofovir Disoproxil Fumarate CAS 202138-50-9
I-Tenofovir Alafenamide Hemifumarate CAS 1392275-56-7
I-Chloromethyl Isopropyl Carbonate CAS 35180-01-9
I-Diethyl (p-Toluenesulfonyloxymethyl)phosphonate CAS 31618-90-3
(R)-(+)-Propylene Carbonate CAS 16606-55-6
(R)-9-(2-Hydroxypropyl)adenine CAS 14047-28-0
I-Diethyl (Hydroxymethyl)phosphonate CAS 3084-40-0
Adenine CAS 73-24-5
Igama leMchiza | I-Tenofovir Disoproxil Fumarate |
Izithethantonye | I-Tenofovir DF;I-Bis(POC)-PMPA Fumarate;GS 4331 Fumarate |
Inombolo yeCAS | 202138-50-9 |
Inombolo yeCAT | RF-API106 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C23H34N5O14P |
Ubunzima beMolekyuli | 635.52 |
Indawo yokunyibilika | 113.0 ukuba 115.0℃ |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe okanye ophantse wamhlophe |
Isazisi A | I-IR Spectrum ihambelana noMgangatho weReferensi |
Isazisi B | Ixesha lokugcinwa kwencopho enkulu kwisisombululo sesampulu sihambelana neso sisombululo siqhelekileyo, njengoko sifunyenwe kuvavanyo. |
Isivavanyi | 98.0% ~ 102.0% (kwisiseko se-anhydrous) |
Amanzi | ≤1.0% |
I-Fumaric Acid | 17.5%~19.0% |
Intsalela kwi-Ignition | ≤0.20% |
Iintsimbi ezinzima | ≤20ppm |
I-Chloromethyl Isopropyl Carbonate | ≤0.15% |
Izinto ezinxulumeneyo | |
I-Tenofovir | ≤0.15% |
Adenine | ≤0.15% |
I-Tenofovir Isoproxi Monoester | ≤1.0% |
Tenofovir Disoproxil Ethyl Ester | ≤0.15% |
I-Tenofovir Isopropyl Isoproxil | ≤0.30% |
I-Tenofovir Disoproxil Carbamate | ≤0.15% |
I-Tenofovir Disproxil | ≤0.15% |
Nakuphi na Ukungacoceki Okukodwa | ≤0.10% |
Ukungcola ngokupheleleyo | ≤2.0% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | API |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-Tenofovir Disoproxil Fumarate (CAS: 202138-50-9), iprodrug ye-tenofovir (Igama loRhwebo: Viread) ephuhliswe yi-Gilead Sciences, luhlobo lwamachiza e-antiretroviral e-nucleotide-analogues, asebenza ngokusebenza njenge-reverse transcriptase inhibitors[nRTIs] , evimba i-reverse transcriptase, i-enzyme ebalulekileyo kwimveliso yentsholongwane kubantu abane-HIV.Kufuneka kuqatshelwe ukuba yi-nucleotide reverse transcriptase inhibitor yokuqala eye yasetyenziselwa unyango losulelo lwe-HIV.I-Tenofovir Disoproxil Fumarate iguqulelwa ekubeni yi-tenofovir kwi-vivo, eyi-acyclic nucleoside phosphonate[nucleotide] analog ye-adenosine 5'-monophosphate.Isetyenziswa ngokubanzi ngokudityaniswa nezinye iintlobo zamayeza.Amayeza e-HIV akanakunyanga i-HIV/AIDS, kodwa ukuthatha indibaniselwano yamayeza e-HIV [abizwa ngokuba yirejimeni ye-HIV] yonke imihla kunokunceda abantu abane-HIV baphile ubomi obude, obunempilo.Ngokusekwe kuxwebhu lwe-FDA, i-tenofovir disoproxil fumarate inokuba yeyonyango lwentsholongwane ye-hepatitis B engapheliyo [HBV] kubantu abadala nakubantwana abaneminyaka eyi-12 nangaphezulu.